Board governance
Governance, board oversight, and company stewardship.
Cilo Cybin Limited supports corporate governance and the outcomes set out in King IV: an ethical culture, performance and value creation, adequate and effective controls, and trust, good reputation, and legitimacy.
This directors area brings together the board of directors, published committee structures, and governance context in one investor-facing destination so stakeholders can review how oversight is structured across the group.
Use the company structure section on the About page to move directly into each entity board or Holdings sub-committee, and use the governance section for related King IV, empowerment, and transformation information.
Board of directors
Cilo Cybin Holdings
Cilo Cybin Holdings board profiles and committee membership are rendered from the current published investor relations entity record.
Dr Tham Seng Kong
Non-Executive · Board Chairperson
Dr Tham is the Founder and Group Chief Executive Officer of ALPS Global Holding Berhad, a life sciences and biotechnology group focused on advanced genomic, cellular, and precision-medicine platforms. He has built ALPS into an internationally operating, regulated healthcare business with capital-markets exposure, including a US public-market presence via Nasdaq. As Chairman of Cilo Cybin Holdings, he provides strong governance oversight, pharmaceutical perspective, and long-term institutional discipline.
Gabriel Christiaan Theron
Executive
Gabriel is the Founder and Chief Executive Officer of Cilo Cybin Holdings and Cilo Cybin (Pty) Ltd. He founded and built the business into South Africa’s only fully vertically integrated GMP cannabis pharmaceutical platform and one of the largest extraction operations globally, leading it from early licensing through to sustained commercial supply. He has founded and successfully operated multiple businesses and led Cilo Cybin as the first cannabis company listed on the JSE, demonstrating both operational depth and capital-markets readiness.
Henk Vivier
Non-Executive
Hendrik Jacobus "Henk" Vivier is an accomplished entrepreneur with an extensive business track record spanning insurance underwriting, financial services, and regulatory advisory. He has been a founding member and director, since 1996, of Senate Corporate Management (Pty) Ltd, an established insurance underwriting business. Between 1998 and 2000, he was a founding member and CEO of AMLAC (the Alliance of Microlenders and Associated Consumers) and served as a board member of the Micro Finance Regulatory Council (now the National Credit Regulato) and has acted as a regulatory advisor to various listed companies, including PSG and African Bank. Since 2011, Mr Vivier has been founder and CEO of Non Perielle Sweetgrass Farms (Pty) Ltd, an agricultural investment company.
Jessica Moodley-Theron
Executive
Jessica is an Executive Director of Cilo Cybin Holdings and Cilo Cybin Pharmaceutical, overseeing strategic relations, international engagement, and long-term growth initiatives. She is currently Acting CFO/FD for Cilo Cybin Holdings. She brings experience across finance, investment facilitation, and cross-border market development, having worked across the UK, Europe, Southern Africa, and the United States. Her work focuses on positioning the business for sustainable international expansion within highly regulated global markets
Mohd Razef Bin Abdullah
Non-Executive · Social & Ethics Committee Chairperson
Sakekile Baduza
Non-Executive · ARMC Committee Chairperson
Audit, risk, financial reporting, and internal-control oversight.
- Sakekile Baduza ARMC chair
- Henk Vivier
- Mohd Razef Bin Abdullah
Remuneration, nomination, and director reward governance.
- Dr Tham Seng Kong
- Mohd Razef Bin Abdullah
- Sakekile Baduza
Social, ethics, transformation, stakeholder, and sustainability oversight.
- Mohd Razef Bin Abdullah Social & Ethics chair
- Dr Tham Seng Kong
- Henk Vivier
Board of directors
Cilo Cybin (Pty) Ltd
Cilo Cybin (Pty) Ltd board profiles and committee membership are rendered from the current published investor relations entity record.
Dr Tham Seng Kong
Non-Executive · Board Chairperson
Dr Tham is the Founder and Group Chief Executive Officer of ALPS Global Holding Berhad, a life sciences and biotechnology group focused on advanced genomic, cellular, and precision-medicine platforms. He has built ALPS into an internationally operating, regulated healthcare business with capital-markets exposure, including a US public-market presence via Nasdaq. As Chairman of Cilo Cybin Holdings, he provides strong governance oversight, pharmaceutical perspective, and long-term institutional discipline.
Gabriel Christiaan Theron
Executive
Gabriel is the Founder and Chief Executive Officer of Cilo Cybin Holdings and Cilo Cybin (Pty) Ltd. He founded and built the business into South Africa’s only fully vertically integrated GMP cannabis pharmaceutical platform and one of the largest extraction operations globally, leading it from early licensing through to sustained commercial supply. He has founded and successfully operated multiple businesses and led Cilo Cybin as the first cannabis company listed on the JSE, demonstrating both operational depth and capital-markets readiness.
Dimitri Shokkos
Executive
Dimitri is a Director & Head of Cultivation at Cilo Cybin (Pty) Ltd, with over two decades of hands-on experience in agricultural and controlled-environment cultivation. He has designed and operated large-scale cannabis cultivation infrastructure and is recognised in South Africa for his technical expertise, contributing deep practical mastery to regulated, pharmaceutical-grade supply.
Jessica Moodley-Theron
Executive
Jessica is an Executive Director of Cilo Cybin Holdings and Cilo Cybin Pharmaceutical, overseeing strategic relations, international engagement, and long-term growth initiatives. She is currently Acting CFO/FD for Cilo Cybin Holdings. She brings experience across finance, investment facilitation, and cross-border market development, having worked across the UK, Europe, Southern Africa, and the United States. Her work focuses on positioning the business for sustainable international expansion within highly regulated global markets
Board of directors
The Green Merchant
The Green Merchant board profiles and committee membership are rendered from the current published investor relations entity record.
Gabriel Christiaan Theron
Executive · Board Chairperson
Gabriel is the Founder and Chief Executive Officer of Cilo Cybin Holdings and Cilo Cybin (Pty) Ltd. He founded and built the business into South Africa’s only fully vertically integrated GMP cannabis pharmaceutical platform and one of the largest extraction operations globally, leading it from early licensing through to sustained commercial supply. He has founded and successfully operated multiple businesses and led Cilo Cybin as the first cannabis company listed on the JSE, demonstrating both operational depth and capital-markets readiness.
Ian McFarlane
Executive
An accomplished commercial leader with over 30 years' experience across the Branded, Generic, and Wholesale sectors of the pharmaceutical and cannabis industries, [Name] combines sharp commercial instinct with a natural flair for communication and relationship-building. Having held Sales & Marketing, Business Development, and Commercial roles up to Director level within multi-national pharmaceutical corporations, [Name] has built and led high-performing teams, forged strategic partnerships spanning the USA to EMEA, and consistently delivered outsized commercial results. Currently Director of Strategic Partnerships at IPS Pharma — the UK's largest importer of medical cannabis, controlling around 65% of all UK cannabis imports — [Name] leads global strategic and business development, building partnerships with growers and international brands to expand patient access to unlicensed medical cannabis across the UK. This role spans the full supply chain, from procurement and quality through to sales, product development, global branding, and the launch of new dosage forms. Career highlights include restructuring a major generics business to double turnover from £75m to £158m in a single year, launching the UK's two largest patent-expiry generic products (Omeprazole and Simvastatin) to £26m in first-day sales, securing a landmark £15m-a-year Joint Venture partnership with AstraZeneca, and managing full acquisition processes including the purchase of DHB Oral Healthcare from administration. Driven by a high need for achievement and a genuine ability to unlock potential in others, [Name] brings three decades of proven commercial leadership, deep industry relationships, and specialist expertise in medical cannabis supply, licensing, and market access.
Jessica Moodley-Theron
Executive
Jessica is an Executive Director of Cilo Cybin Holdings and Cilo Cybin Pharmaceutical, overseeing strategic relations, international engagement, and long-term growth initiatives. She is currently Acting CFO/FD for Cilo Cybin Holdings. She brings experience across finance, investment facilitation, and cross-border market development, having worked across the UK, Europe, Southern Africa, and the United States. Her work focuses on positioning the business for sustainable international expansion within highly regulated global markets
Dr. Tham Seng Kong
Non-Executive
Mr. Brandon Rodney Topham
Non-Executive
Mr. Kovinder Maroothanaden
Non-Executive